Sort   by:  
 Page size 
UnknownImpact of Precision Medicine in Diverse Cancers: A Meta-Analysis of Phase II Clinical Trials.
Not available
S-EPMC4737863 | biostudies-literature
UnknownInitiative for Molecular Profiling and Advanced Cancer Therapy (IMPACT): An MD Anderson Precision Medicine Study.
Not available
S-EPMC5659750 | biostudies-literature
UnknownAn appraisal of drug development timelines in the Era of precision oncology.
Not available
S-EPMC5288167 | biostudies-literature
UnknownTumor Infiltrating Lymphocyte Expression of PD-1 Predicts Response to Anti-PD-1/PD-L1 Immunotherapy.
Not available
S-EPMC9714418 | biostudies-literature
UnknownPhase I Study of LY2606368, a Checkpoint Kinase 1 Inhibitor, in Patients With Advanced Cancer.
Not available
S-EPMC5321045 | biostudies-literature
UnknownTotal Number of Alterations in Liquid Biopsies Is an Independent Predictor of Survival in Patients With Advanced Cancers.
Not available
S-EPMC7450932 | biostudies-literature
UnknownMapping the landscape of predictive biomarkers for immune checkpoint inhibitors a bibliometric analysis.
Not available
S-EPMC12756203 | biostudies-literature
UnknownCorrelation between tumor size change and outcome in a rare cancer immunotherapy basket trial.
Not available
S-EPMC11077308 | biostudies-literature
UnknownPhase I study evaluating the combination of lapatinib (a Her2/Neu and EGFR inhibitor) and everolimus (an mTOR inhibitor) in patients with advanced cancers: South West Oncology Group (SWOG) Study S0528.
Not available
S-EPMC4072025 | biostudies-literature
UnknownDigital Display Precision Predictor: the prototype of a global biomarker model to guide treatments with targeted therapy and predict progression-free survival.
Not available
S-EPMC8080819 | biostudies-literature
Sort   by:  
 Page size